Elutia Inc (ELUT)
3.47
-0.36
(-9.40%)
USD |
NASDAQ |
Nov 15, 16:00
3.47
0.00 (0.00%)
After-Hours: 20:00
Elutia Research and Development Expense (Quarterly): 1.001M for June 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.001M |
| March 31, 2024 | 1.172M |
| December 31, 2023 | 1.383M |
| September 30, 2023 | 0.557M |
| June 30, 2023 | 0.869M |
| March 31, 2023 | 1.591M |
| December 31, 2022 | 1.86M |
| September 30, 2022 | 1.723M |
| June 30, 2022 | 2.617M |
| March 31, 2022 | 2.272M |
| Date | Value |
|---|---|
| December 31, 2021 | 3.376M |
| September 30, 2021 | 2.289M |
| June 30, 2021 | 1.881M |
| March 31, 2021 | 1.72M |
| December 31, 2020 | 1.973M |
| September 30, 2020 | 1.264M |
| June 30, 2020 | 1.408M |
| March 31, 2020 | 1.309M |
| December 31, 2019 | 0.658M |
| September 30, 2019 | 0.507M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.557M
Minimum
Sep 2023
3.376M
Maximum
Dec 2021
1.628M
Average
1.591M
Median
Mar 2023
Research and Development Expense (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 9.275M |
| Retractable Technologies Inc | 0.1991M |
| InfuSystems Holdings Inc | -- |
| Xtant Medical Holdings Inc | 0.636M |
| Catheter Precision Inc | 0.081M |